Your browser doesn't support javascript.
loading
Rituximab versus cyclophosphamide for remission induction in active, severe antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Chung et al.
Jain, Siddharth; Naidu, G S R S N K; Sharma, Aman.
Affiliation
  • Jain S; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Naidu GSRSNK; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sharma A; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Arthritis Rheumatol ; 74(3): 544-545, 2022 03.
Article in En | MEDLINE | ID: mdl-34694068
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Antineutrophil Cytoplasmic / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2022 Document type: Article Affiliation country: India Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Antineutrophil Cytoplasmic / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2022 Document type: Article Affiliation country: India Country of publication: United States